NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reported today that it has received a notice from the NYSE American LLC, dated April 18, 2024, indicating that the Company is currently below compliance with the NYSE American continued listing standards as outlined…
On July 4, 2023, Lafayette, Louisiana experienced a seemingly typical Fourth of July, with kids playing soccer, families preparing for barbecues, and the familiar Louisiana heat enveloping the town. However, this day was marked by an intense heatwave, making it…
Australia’s Latest Biotech Incubator, Jumar Bioincubator, Unveils First Cohort of Innovative Ventures Melbourne, Australia – Jumar Bioincubator, the newest addition to Australia’s biotech landscape, has officially opened its doors, showcasing 16 pioneering early-stage ventures at its eagerly anticipated Melbourne facility.…
AstraZeneca is gearing up to present a wealth of new clinical, real-world, and early science data encompassing its Vaccines & Immune Therapies portfolio at the 34th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Barcelona, Spain from April…
Labcorp, a leading provider of innovative laboratory services globally, has announced the launch of the nation’s inaugural glial fibrillary acidic protein (GFAP) test. This test serves as a pivotal blood-based biomarker aiding in the early detection of neurodegenerative diseases and…
A recent modeling analysis conducted by AstraZeneca, named IMPACT CKD, projects that by 2032, up to 16.5% of the population across eight countries will be afflicted by chronic kidney disease (CKD), with an expected increase of up to 59.3% in…
Introducing the latest addition to ResearchAndMarkets.com’s offerings, the report on the “Global Dermal Fillers Market, 2023-2035”. Estimated at $3 billion in 2023, the global dermal fillers market is poised for robust growth, projected at a compound annual growth rate (CAGR)…
Ipsen (Euronext: IPN; ADR: IPSEY) has announced the approval by the U.S. Food and Drug Administration (FDA) of the supplemental new drug application for Onivyde® (irinotecan liposome injection) in combination with oxaliplatin, fluorouracil, and leucovorin (NALIRIFOX) as a first-line therapy…
Lupin Limited, a leading global pharmaceutical company, announced today that the United States Food and Drug Administration (U.S. FDA) has successfully completed a Good Manufacturing Practice (GMP) Inspection of its Active Pharmaceutical Ingredient (API) manufacturing facility situated in Dabhasa, India.…
In a groundbreaking development, Nigeria has emerged as the global pioneer in introducing a new vaccine, known as Men5CV, endorsed by the World Health Organization (WHO). This innovative vaccine provides protection against five strains of the meningococcus bacteria. The initiative,…
Baxter International Inc. (NYSE:BAX), renowned globally for its excellence in injectables, anesthesia, and drug compounding, has unveiled a significant expansion of its Pharmaceuticals portfolio with the introduction of five new injectable products in the United States. Alok Sonig, Executive Vice…
As the daughter of immigrants, Gabriela Ziccarelli, PharmD, BCACP, is deeply committed to reducing health disparities, particularly among minority communities. With nearly two decades at Walgreens, she has dedicated much of her career to serving in underrepresented areas where Spanish…